Tacrine Hydrochloride has been shown to reversibly inhibit acetylcholine esterase (AChE). This compound has been reported to display hepatotoxicity, more specifically causing pericentral necrosis and fat degeneration of hepatocytes. Additionally, tacrine hydrochloride has demonstrated the ability to cause a decrease in liver glycogens and an increase in Heme Oxygenase 1. Other experiments suggest that tacrine hydrochloride causes functional and morphological changes in the endoplasmic reticulum, ribosome, and mitochondria of the liver via DNA synthesis impairment. Tacrine hydrochloride is an inhibitor of butyrylcholinesterase (BChE).
1. Summers, W.K., et al. 1986. N. Engl. J. Med. 315: 1241-1245. PMID: 2430180
2. Robertson, D.G., et al. 1998. Arch. Toxicol. 72: 362-371. PMID: 9657284
3. Lupp, A., et al. 2010. Arzneimittelforschung. 60: 229-237. PMID: 20533758
See how others have used Tacrine Hydrochloride (CAS 1684-40-8). Click on the entry to view the PubMed entry .
PMID: # 29407385 Xu, J.|Oda, S.|Yokoi, T.| et al. 2018. Toxicol In Vitro. 48: 286-301.
PMID: # 32717485 Eur J Med Chem. 112623.
PMID: # 31668517 Cell Chem Biol. 1664-1680.e4.
PMID: # 31919413 Cell Death Dis. 11: 2.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.